| Beth L Valderrama, PA-C | |
|
95 Highland Ave, Suite 130, Bethlehem, PA 18017-9424 | |
| (610) 868-1100 | |
| (610) 868-1111 |
| Full Name | Beth L Valderrama |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 33 Years |
| Location | 95 Highland Ave, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003817917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | MA001545L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| St Luke's Warren Hospital | Phillipsburg, NJ | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
| St Lukes Warren Physician Group Pc | 9739093675 | 314 |
News Archive
Like an emergency response team that is called into action to save lives, stress response proteins in the heart are activated during a heart attack to help prevent cell death.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Type 1 diabetes (T1D) patients on insulin pumps stand to benefit by engaging in aerobic exercise, said a team researchers who conducted a three-month observational study on two groups of diabetes patients.
GPC Biotech AG has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for satraplatin in combination with prednisone for patients with hormone-refractory prostate cancer (HRPC) whose prior chemotherapy has failed.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the year was $262 million, up 46% from $179 million in 2008, exceeding the company's 2009 guidance of $223 million to $243 million, as adjusted to reflect the inclusion of two new partner companies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Beth L Valderrama, PA-C 95 Highland Ave, Suite 130, Bethlehem, PA 18017-9424 Ph: (610) 868-1100 | Beth L Valderrama, PA-C 95 Highland Ave, Suite 130, Bethlehem, PA 18017-9424 Ph: (610) 868-1100 |
News Archive
Like an emergency response team that is called into action to save lives, stress response proteins in the heart are activated during a heart attack to help prevent cell death.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
Type 1 diabetes (T1D) patients on insulin pumps stand to benefit by engaging in aerobic exercise, said a team researchers who conducted a three-month observational study on two groups of diabetes patients.
GPC Biotech AG has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for satraplatin in combination with prednisone for patients with hormone-refractory prostate cancer (HRPC) whose prior chemotherapy has failed.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the year was $262 million, up 46% from $179 million in 2008, exceeding the company's 2009 guidance of $223 million to $243 million, as adjusted to reflect the inclusion of two new partner companies.
› Verified 9 days ago
Mrs. Tiffany Marie Ostroski, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Road, 5th Floor Lvh-m South, Bethlehem, PA 18017 Phone: 484-884-6503 Fax: 484-884-6504 | |
Ashley Jessen, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2775 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-402-8900 Fax: 610-861-0258 | |
Danielle L Dustman, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St # Street2, Bethlehem, PA 18015 Phone: 484-526-1735 | |
Laura Dohm, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2649 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-4799 | |
Rebecca Rasmuson, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-2200 | |
Christopher George Brinkman, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 866-785-8537 |